Search

Search Constraints

You searched for: Author/Creator Seiwert, Tanguy Y.

Search Results

1. A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101. (March 2021)

2. A pilot study of the pan‐class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer. Issue 11 (4th September 2019)

3. A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Issue 10 (19th February 2020)

4. A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study. Issue 14 (4th May 2020)

5. An Immunogenomic Investigation of Oral Cavity Squamous Cell Carcinoma in Patients Aged 45 Years and Younger. (16th April 2020)

6. Biomarkers predictive of response to pembrolizumab in head and neck cancer. (7th December 2022)

7. Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040). Issue 1 (3rd April 2019)

8. Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer. (May 2022)

9. Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience. (May 2018)